User profiles for Jane C. Parker

Jane Parker

Professor of Employment Relations and HRM, Massey University
Verified email at massey.ac.nz
Cited by 9608

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

…, SC Morpeth, S Murthy, K Orr, RL Parke, JC Parker… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

…, PR Mouncey, K Orr, R Parke, JC Parker… - Intensive care …, 2021 - Springer
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …

Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain …

…, K Ogungbenro, KO BPharm, RL Parke, JC Parker… - MedRxiv, 2021 - medrxiv.org
BACKGROUND The interleukin-6 receptor antagonist tocilizumab improves outcomes in
critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of …

[HTML][HTML] Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial

…, S Murthy, MD Neal, AD Nichol, RL Parke, JC Parker… - Jama, 2022 - ncbi.nlm.nih.gov
Interventions Patients were randomized to receive either open-label aspirin (n= 565), a
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …

Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19.

…, S Murthy, MD Neal, AD Nichol, RL Parke, JC Parker… - 2022 - cabidigitallibrary.org
IMPORTANCE: The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is
uncertain. OBJECTIVE: To determine whether antiplatelet therapy improves outcomes for …

Predictors of subjective fatigue among individuals with rheumatoid arthritis

BA Huyser, JC Parker, R Thoreson… - Arthritis & …, 1998 - Wiley Online Library
Objective To examine a range of variables potentially associated with rheumatoid arthritis (RA)‐related
fatigue and to determine which variables best predict subjective fatigue. Methods …

Self‐efficacy predicting outcome among fibromyalgia subjects

…, JC Johnson, R Conway, JC Parker… - … : Official Journal of …, 1996 - Wiley Online Library
Objectives. This study examined whether pretreatment self‐efficacy and pre‐ to post‐treatment
changes in self‐efficacy predict post‐treatment tender point index, disease severity, pain, …

Effects of stress management on clinical outcomes in rheumatoid arthritis

JC Parker, KL Smarr, SP Buckelew… - Arthritis & …, 1995 - Wiley Online Library
Objective. To examine the effects of stress‐management training on clinical outcomes in
persons with rheumatoid arthritis (RA). Methods. Patients with RA (n = 141) were randomly …

[PDF][PDF] Reinventing the high school government course: Rigor, simulations, and learning from text

WC Parker, JC Lo - Democracy & Education, 2016 - diginole.lib.fsu.edu
he high school government course is arguably the main site of formal civic education in the
country today. his article presents the curriculum that resulted from a multiyear study aimed at …

Age, depressive symptoms, and rheumatoid arthritis

GE Wright, JC Parker, KL Smarr… - … : Official Journal of …, 1998 - Wiley Online Library
Objective To examine the relationship between age and depression in persons with rheumatoid
arthritis (RA). Methods Two separate outpatient cohorts of persons with RA were studied…